Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.

ABSTRACT: Schlemm's canal (SC) is a unique, complex vascular structure responsible for maintaining fluid homeostasis within the anterior segment of the eye by draining the excess of aqueous humour. In glaucoma, a heterogeneous group of eye disorders afflicting approximately 60 million individuals worldwide, the normal outflow of aqueous humour into SC is progressively hindered, leading to a gradual increase in outflow resistance, which gradually results in elevated intraocular pressure (IOP). By and large available antiglaucoma therapies do not target the site of the pathology (SC), but rather aim to decrease IOP by other mechanisms, either reducing aqueous production or by diverting aqueous flow through the unconventional outflow system. The present review first outlines our current understanding o

SUBMITTER: Andres-Guerrero V 

PROVIDER: S-EPMC5427152 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature